California AG Says Paramount-WBD Merger Would Hurt the State

California Attorney General Rob Bonta said he is confident in the antitrust lawsuit seeking to block Paramount Skydance's proposed $110 billion acquisition of Warner Bros. Discovery. Paramount has threatened to leave California if the transaction fails, although Bonta said he wants to avoid that outcome and is open to good-faith discussions. The legal challenge creates material execution risk for a major media-sector consolidation.

Analysis

The market should treat California as a meaningful incremental closing-risk variable rather than a headline-only objection: a state challenge can extend the timetable, increase behavioral-remedy costs, and create discovery that gives federal regulators additional leverage. For WBD, a longer review period raises the probability that standalone deleveraging and linear-TV erosion again become the dominant valuation drivers; for PSKY, the near-term effect is likely relief from financing and integration-risk overhang, but that benefit depends on whether the buyer has already committed material break-fee or financing costs.

The non-obvious issue is bargaining power. A credible threat to relocate operations may be intended to convert an outright challenge into a negotiated remedy, but employment or production commitments would reduce post-deal synergies and make any agreed transaction less accretive than the headline enterprise value implies. Over the next 1-3 months, court scheduling, any preliminary-injunction request, and disclosure of remedy discussions matter more than political rhetoric; over 6-18 months, a failed transaction would leave WBD exposed to renewed pressure for asset sales, while PSKY would need to articulate an alternative use of capital.

Consensus may overstate the binary probability of termination. Antitrust remedies can preserve a path to closing, yet a remedy-heavy outcome is not equivalent to a clean win for PSKY: reduced content, distribution, or production synergies would warrant multiple compression even if the deal survives. The key falsifier for a negative WBD view is evidence that the consideration materially exceeds WBD's unaffected value and is protected by a substantial reverse termination fee; those deal terms are necessary before sizing a conventional merger-arbitrage position.

Key Decisions for Investors

• Do not initiate a directional WBD long solely on deal optionality until the consideration mix, collar mechanics, financing conditions, and termination-fee structure are verified. If WBD trades at a widening discount to disclosed consideration after a formal injunction filing, assess a small, hedged merger-arbitrage long with exposure capped to the standalone-value gap.
• Maintain a tactical long PSKY / short WBD pair for a 1-3 month regulatory-escalation window only if the pair has not already repriced materially: the thesis is buyer relief versus target premium erosion. Exit on a negotiated California remedy or federal clearance signal; the primary risk is a settlement that restores closing probability without materially impairing synergies.
• Use WBD put spreads, rather than outright short stock, to express a failed-deal scenario where terms remain opaque. Size around the next court-scheduling or injunction catalyst, with maximum premium loss defined; a favorable settlement or a higher bid is the principal upside-tail risk.
• Set an event-driven alert for any disclosed operational commitments, divestitures, or content/distribution remedies. A remedy package that preserves the transaction but reduces recurring synergies would be bearish PSKY even if it is initially interpreted as clearance-positive.